Clinical Trials Directory

Trials / Completed

CompletedNCT05982743

Lactobacillus Casei Strain Shirota Fermented Milk for Alleviating Hard Stools in Vietnam

A Pilot Study of Using Fermented Milk Containing Lactobacillus Casei Strain Shirota (LcS) in Some Constipated Adults Having High Prevalence of Hard Stools in Vietnam

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
51 (actual)
Sponsor
Yakult Honsha Co., LTD · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to provide evidence supporting the efficacy of fermented milk containing Lactobacillus casei strain Shirota in alleviating hard or lumpy stools. A randomized, controlled trial has been designed on constipated adults with a high prevalence of hard stools in Vietnam.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLactobacillus casei strain Shirota fermented milkParticipants will take one bottle (65 ml) of Yakult® drink daily, containing at least 6.5 x 10\^9 CFU of Lactobacillus casei strain Shirota, for a period of 4 weeks. Subsequently, there will be a two-week follow-up period.

Timeline

Start date
2022-05-11
Primary completion
2023-03-08
Completion
2023-03-08
First posted
2023-08-09
Last updated
2023-08-14

Locations

1 site across 1 country: Vietnam

Source: ClinicalTrials.gov record NCT05982743. Inclusion in this directory is not an endorsement.